Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-120035

President and CEO acquired 1,317,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2026-11-12 Grant or award +629,000 4,769,505 D
KIDRON NADAV President and CEO 2026-11-12 Grant or award +688,000 5,457,505 D
Loading xslF345X06/ownership.xml…